In search of enriching the scientific and technological community, the Puerto Rico Science, Technology and Research Trust (FCTIPR) received Dr. Vijay Chandru, who gave a talk to professionals from Puerto Rico on ways to integrate 21st century digital tools in research and medicine.
“The opportunity to hear from an expert in this field is aligned with our vision of Puerto Rico being a globally recognized innovation center. In this era, computing and programming technologies have advanced tremendously and have become well accessible to the population.highlighted the engineer Lucy Crespoexecutive director of the FCTIPR.
Chandru, a native of Bangalore, India, gave the presentation “Recombinant Innovation with Intelligent and Living Machines” before a select group of researchers, experts in innovative medical therapies and leaders of research and educational organizations.
During his visit to Puerto Rico, the academic, businessman and translational research advisor shared his experiences and vision on the integration of advanced technologies as the artificial intelligence generation, next-generation deoxyribonucleic acid (DNA) sequencing and quantum computing, and how these can be applied to address global challenges such as climate changehealth and food safety.
With a doctorate in Science Massachusetts Institute of Technology (MIT), Chandru is an influential figure in technological innovation and health. He has been a full professor of computational mathematics at the Purdue University and in the Indian Institute of Science (IISc).
In his current role, he works with a large team at ARTPark and IISc to develop public digital infrastructure in clinical health, comprehensive health and climate, as well as for technological development of the use of artificial intelligence using Indian languages and dialects, in collaboration with entities public health and local governments. Additionally, she co-chairs the technology working group of the Citizen Commission of The Lancet to reimagine healthcare systems in India.
The academic is also an executive consultant for Smartweavean innovative medical device design platform that uses artificial intelligence and visual technology to produce personalized, biocompatible implants for soft tissue repair.
Dr. Chandru’s commitment, both at Smartweave and other organizations, focuses on ensuring that “no disease is orphaned” by 2030, guaranteeing adequate and personalized treatments for all patients.